Chester County News and Community Website
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week that Part 2 of its Phase 2 clinical trial for VP-315, a potential first-in-class oncolytic peptide, has yielded …
Verrica Pharmaceuticals Reports Promising Phase 2 Results for VP-315 in Basal Cell Carcinoma Read More
BERWYN, PA — Panavance Therapeutics Inc. has announced the publication of encouraging data on misetionamide in the peer-reviewed journal, Cancer Medicine. The study conducted by Kim et al. at MD …
Panavance Therapeutics Reports Positive Data on Misetionamide in Ovarian Cancer Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has released its financial results for the second quarter ending June 30, 2024, alongside significant business updates that highlight the company’s strategic …
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Progress in Clinical Trials Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced that it will present significant interim findings from its randomized Phase 1b FURTHER study on firmonertinib monotherapy. This presentation …
ArriVent BioPharma to Present Groundbreaking Data at 2024 World Conference on Lung Cancer Read More
SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) has announced encouraging results from the Phase 2 UNITY study evaluating nipocalimab for treating pregnant individuals at risk of early onset …
Johnson & Johnson Announces Promising Phase 2 Study Results for Nipocalimab in Treating Severe HDFN Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) announced new preclinical data showing the positive combined effects of its lead compound, buntanetap, with the GLP-1 agonist dulaglutide (Trulicity®) in an …
Annovis Bio Shows Synergistic Effect of Buntanetap and Dulaglutide in Alzheimer’s Treatment Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotech firm based in Bucks County, has shared significant updates on its novel heart failure therapy, istaroxime. This therapy aims to …
Windtree Therapeutics Advances Heart Failure Treatment in New Clinical Trials Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced the completion of dosing in the third cohort of its Phase 1/2 ArMaDa clinical trial for OCU410, a novel gene …
Ocugen Completes Dosing in Phase 1/2 Trial for Gene Therapy to Treat Geographic Atrophy Read More
PHILADELPHIA, PA — Vittoria Biotherapeutics announced a significant publication by University of Pennsylvania investigators in Science Immunology. The paper highlights the role of CD5, an immunomodulatory protein, in enhancing engineered …
Vittoria Biotherapeutics’ Senza5 Platform Featured in Science Immunology Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced the publication of a clinical study highlighting the effectiveness of its TheraClear®X Acne Therapy System. The study, titled “Advancing …
STRATA Skin Sciences Publishes Promising Acne Therapy Study Read More